2024 - Advancing Epilepsy Research: New Strategies for Drug-Resistant Epilepsy and Associated Comorbidities

Epilepsy is a chronic neurological disorder marked by recurring seizures and frequently accompanied by various comorbidities, including motor deficits, attention deficit hyperactivity disorder (ADHD), anxiety, depression and cognitive impairment.
Despite numerous available therapies, seizures in approximately 30 percent of epilepsy patients are not completely managed by available therapies. This webinar will delve into the urgent need to revamp therapy discovery strategies to better address drug-resistant epilepsy and highlight the importance of tackling the associated comorbidities.
Traditionally, antiseizure medication (ASM) discovery has relied on efficacy demonstrated with rodent in vivo seizure models such as maximal electroshock, subcutaneous pentylenetetrazol and kindling. However, recent advances in genetic sequencing technologies have facilitated an opportunity to better address the pressing medical needs of individuals with treatment-resistant epilepsy through the strategic use of syndrome-specific epilepsy models to discover novel compounds.
Read more...
Register for this webinar today to understand how next-generation drug discovery is being pursued by integrating syndrome-specific models into epilepsy research.
Keywords: Drug Development, Drug Discovery, CRO, Epilepsy, Therapeutic Areas, CNS, Neurological Disease, Neurology, Neurological Disorder, Basic Research, DEE